Healthcare Triangle, Inc. Announces Approval of $2 Million Share Repurchase Plan

Rhea-AI Summary

Healthcare Triangle (Nasdaq: HCTI) announced that its Board approved a $2,000,000 share repurchase plan on March 9, 2026, effective immediately. The plan permits repurchases via open-market or negotiated transactions, including Rule 10b-18 and Rule 10b5-1 plans, funded from available cash or other liquidity.

The program is discretionary, may be suspended or discontinued, and does not obligate the company to repurchase any specific amount; repurchased shares may be held as treasury stock or retired.

Positive

• Board authorized a $2,000,000 share repurchase plan approved March 9, 2026
• Program allows repurchases under Rule 10b-18 and 10b5-1 trading plans

Negative

• Company is not obligated to repurchase any shares under the program
• Repurchase program may be suspended, modified, or discontinued at management's discretion

News Market Reaction – HCTI

-4.25%

24 alerts

-4.25% News Effect

+29.2% Peak Tracked

-2.8% Trough Tracked

-$169K Valuation Impact

$4M Market Cap

0.2x Rel. Volume

On the day this news was published, HCTI declined 4.25%, reflecting a moderate negative market reaction. Argus tracked a peak move of +29.2% during that session. Argus tracked a trough of -2.8% from its starting point during tracking. Our momentum scanner triggered 24 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $169K from the company's valuation, bringing the market cap to $4M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Share repurchase authorization: $2,000,000

1 metrics

Share repurchase authorization $2,000,000 Maximum aggregate amount under the 2026 Share Repurchase Plan approved March 9, 2026

Market Reality Check

Price: $2.62 Vol: Volume 115,551 is 0.1x th...

low vol

$2.62 Last Close

Volume Volume 115,551 is 0.1x the 20-day average of 1,178,596, indicating subdued pre-news trading. low

Technical Shares trade below the 200-day MA of 164.1 at a pre-news price of 2.72, reflecting a longer-term downtrend.

Peers on Argus

Sector scanner shows 2 peers moving up (median about 1.6%) and 1 down, with HCTI...

2 Up 1 Down

Sector scanner shows 2 peers moving up (median about 1.6%) and 1 down, with HCTI flagged as moving up in that scan. This points to broader sector momentum rather than a purely isolated move.

Common Catalyst One close peer (DRIO) has an earnings-related date announcement, but most peer moves appear momentum-driven rather than tied to common fundamentals.

Historical Context

5 past events · Latest: Feb 27 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 27	International expansion	Positive	-17.5%	Launch of Dubai operations for digital health and AI solutions in GCC markets.
Feb 26	Equity financing	Negative	-13.6%	Registered direct offering of common stock and pre-funded warrants for ~$3.959M.
Feb 25	Strategic partnership	Positive	-1.0%	Partnership with TNG Digital to provide digital mental health services to 25M users.
Feb 06	Reverse stock split	Negative	-28.8%	1-for-60 reverse split to support compliance with Nasdaq minimum bid rules.
Feb 05	AI JV announcement	Positive	-7.0%	Joint venture to target the $70B Saudi healthcare market by 2030 with AI platforms.

Pattern Detected

Recent corporate and growth announcements have often been followed by negative price reactions, including to financing and strategic news.

Recent Company History

Over the last few months, HCTI reported multiple strategic initiatives and capital actions. A 1-for-60 reverse split and subsequent registered direct financing at $5.81 per share were followed by double-digit declines. International expansion and partnerships in the UAE, Malaysia, and Saudi Arabia also saw negative or muted 24-hour reactions. Against this backdrop, the new $2,000,000 buyback plan arrives after a series of dilutive and restructuring events.

Regulatory & Risk Context

Active S-3 Shelf · $2.85 million

Shelf Active

Active S-3 Shelf Registration 2025-11-19

$2.85 million registered capacity

HCTI has an effective Form S-3/A shelf amendment filed on 2025-11-19 registering 1,458,118 resale shares tied to inducement and advisor warrants. The company already received $2.85 million from prior warrant exercises and may receive additional cash at a $3.00 exercise price. The filing notes that adding freely tradable resale shares could pressure the stock and dilute existing holders.

Market Pulse Summary

This announcement introduces a $2,000,000 share repurchase plan, giving management discretion to buy...

Analysis

This announcement introduces a $2,000,000 share repurchase plan, giving management discretion to buy back stock via open-market or negotiated transactions under Rules 10b-18 and 10b5-1. It follows a period of reverse split, equity financing, and active use of an effective shelf registration for 1,458,118 resale shares. Key factors to monitor include the actual pace of repurchases versus prior and potential new share issuance and overall liquidity needs.

Key Terms

share repurchase program, rule 10b-18, rule 10b5-1, treasury stock, +1 more

5 terms

share repurchase program financial

"its Board of Directors has approved a share repurchase program authorizing the Company"

A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.

rule 10b-18 regulatory

"Repurchases may be conducted pursuant to Rule 10b-18 under the Securities Exchange Act of 1934"

Rule 10b-18 is a regulation that sets strict rules for how a company's executives and employees can buy back their own company's stock from the market. It helps ensure that these buybacks happen in a fair and transparent way, reducing the chance of market manipulation. This is important for investors because it offers protection against unfair practices and promotes confidence in the integrity of the stock market.

rule 10b5-1 regulatory

"as well as under Rule 10b5-1 trading plans that may be adopted by the Company"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

treasury stock financial

"Any shares repurchased under the program may be held as treasury stock or retired"

Treasury stock is shares that a company has bought back from the public and kept in its own control rather than retiring them. Think of it like a company holding its own tickets in a drawer: those shares no longer vote or receive dividends while held, but the company can reissue or retire them later; this reduces the number of shares available to outside investors and can boost per‑share earnings and influence ownership and stock price.

securities and exchange commission regulatory

"making required filings with the Securities and Exchange Commission. The Company may fund"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. Not financial advice.

PLEASANTON, Calif., March 11, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announces that its Board of Directors has approved a share repurchase program authorizing the Company to repurchase up to $2,000,000 of its outstanding common stock ("2026 Share Repurchase Plan"). The 2026 Share Repurchase Plan was approved by the Company's Board of Directors on March 9, 2026, and became effective immediately.

Under the newly authorized plan, the Company may repurchase shares of its common stock from time to time through open market transactions, privately negotiated transactions, or other means in accordance with applicable securities laws and regulations. Repurchases may be conducted pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as well as under Rule 10b5-1 trading plans that may be adopted by the Company. The timing, volume, and nature of repurchases will be determined by management at its discretion based on market conditions, the trading price of the Company's common stock, corporate liquidity requirements, applicable legal requirements, and other factors.

The repurchase program authorizes purchases of up to an aggregate of $2,000,000 of the Company's common stock. The program does not obligate the Company to acquire any particular amount of shares, and the program may be suspended, modified, or discontinued at any time at the Company's discretion. Any shares repurchased under the program may be held as treasury stock or retired, as determined by the Company.

"The approval of this share repurchase program reflects the Board's commitment to prudent capital allocation and its confidence in the Company's long-term strategy," said David Ayanoglou, Chief Financial Officer of Healthcare Triangle, Inc. "The program provides the Company with flexibility to opportunistically repurchase shares while continuing to support our operational and strategic priorities."

The Board also authorized the Company's officers to take all necessary actions to implement the plan, including engaging qualified brokers and making required filings with the Securities and Exchange Commission. The Company may fund repurchases under the program using available cash and cash equivalents or other sources of liquidity.

About Healthcare Triangle

Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization. For more information, please visit www.healthcaretriangle.com

Forward-Looking Statement:

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the Company's share repurchase program, including the timing, amount, and method of any repurchases. These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which Healthcare Triangle, Inc. operates, as well as management's beliefs and assumptions. Forward-looking statements include, but are not limited to, statements regarding revenue growth, margin expansion, market opportunities, and strategic initiatives. These statements involve risks, uncertainties, and assumptions that are difficult to predict. Actual outcomes may differ materially from those expressed or implied in any forward-looking statements due to various factors beyond the company's control, including changes in market conditions, client demand, regulatory developments, and execution risks. Readers are cautioned not to place undue reliance on these forward-looking statements. Healthcare Triangle, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Investors:

1-800-617-9550  

ir@healthcaretriangle.com

View original content:https://www.prnewswire.com/news-releases/healthcare-triangle-inc-announces-approval-of-2-million-share-repurchase-plan-302711127.html

SOURCE Healthcare Triangle, Inc.

FAQ

What did Healthcare Triangle (HCTI) authorize in its March 11, 2026 announcement?

The company authorized a $2,000,000 share repurchase plan approved March 9, 2026. According to the company, repurchases may occur via open-market or negotiated transactions and are effective immediately.

How will Healthcare Triangle (HCTI) execute the $2,000,000 repurchase plan?

Repurchases may be executed through open-market trades, privately negotiated transactions, or other lawful means. According to the company, purchases can follow Rule 10b-18 or adopt Rule 10b5-1 trading plans for execution.

What funding sources will Healthcare Triangle (HCTI) use for the share buyback?

The company may fund repurchases using available cash, cash equivalents, or other sources of liquidity. According to the company, management will consider corporate liquidity requirements before executing purchases.

Does the HCTI repurchase plan obligate Healthcare Triangle to buy shares?

No, the program does not obligate the company to acquire any specific number of shares. According to the company, the plan may be suspended, modified, or discontinued at any time.

Will repurchased Healthcare Triangle (HCTI) shares be retired or held as treasury stock?

Repurchased shares may be either held as treasury stock or retired, as determined by the company. According to the company, the final treatment of repurchased shares will be decided by management.